M T Dransfield

Summary

Country: USA

Publications

  1. ncbi Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Clin Infect Dis 55:e35-44. 2012
  2. ncbi N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD
    Philip O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1900 University Blvd, Birmingham, Alabama 35294 0006, USA
    Respir Res 10:38. 2009
  3. ncbi Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD
    Mark T Dransfield
    University of Alabama Birmingham Lung Health Center, University of Alabama at Birmingham, The Birmingham VA Medical Center, Birmingham, AL, USA
    Respir Med 105:1322-30. 2011
  4. ncbi CT emphysema predicts thoracic aortic calcification in smokers with and without COPD
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama
    COPD 7:404-10. 2010
  5. ncbi Disease severity and symptoms among patients receiving monotherapy for COPD
    Mark T Dransfield
    UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Prim Care Respir J 20:46-53. 2011
  6. ncbi Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Am J Respir Crit Care Med 180:499-505. 2009
  7. ncbi Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment
    deNay P Kirkpatrick
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Blvd, Birmingham, AL 35294, USA
    Curr Opin Pulm Med 15:100-4. 2009
  8. ncbi Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
    M T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Blvd, Birmingham, Alabama 35294, USA
    Thorax 63:301-5. 2008
  9. ncbi COPD: racial disparities in susceptibility, treatment, and outcomes
    Mark T Dransfield
    Pulmonary Section, Birmingham VA Medical Center, Birmingham, AL 35294, USA
    Clin Chest Med 27:463-71, vii. 2006
  10. ncbi Improving the lung cancer resection rate in the US Department of Veterans Affairs Health System
    Mark Thomas Dransfield
    Division of Pulmonary, Allergy, and Critical Care Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Clin Lung Cancer 7:268-72. 2006

Detail Information

Publications16

  1. ncbi Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Clin Infect Dis 55:e35-44. 2012
    ..We hypothesized that these advantages would persist at 1 and 2 years...
  2. ncbi N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD
    Philip O'Reilly
    Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, THT 422, 1900 University Blvd, Birmingham, Alabama 35294 0006, USA
    Respir Res 10:38. 2009
    ..In this study, we investigate if N-alpha-PGP and PGP are biomarkers and potential therapeutic targets for COPD...
  3. ncbi Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD
    Mark T Dransfield
    University of Alabama Birmingham Lung Health Center, University of Alabama at Birmingham, The Birmingham VA Medical Center, Birmingham, AL, USA
    Respir Med 105:1322-30. 2011
    ..Prior studies suggest that fluticasone propionate/salmeterol (FSC) may improve cardiovascular outcomes in COPD and we hypothesized that FSC would reduce arterial stiffness in these patients...
  4. ncbi CT emphysema predicts thoracic aortic calcification in smokers with and without COPD
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama
    COPD 7:404-10. 2010
    ..We conclude that CT emphysema is independently associated with thoracic calcification and thus may be used to assess cardiovascular risk in smokers with and without COPD...
  5. ncbi Disease severity and symptoms among patients receiving monotherapy for COPD
    Mark T Dransfield
    UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Prim Care Respir J 20:46-53. 2011
    ..To examine the burden of respiratory symptoms, quality of life and co-morbid illness in COPD patients receiving maintenance treatment in a real world setting...
  6. ncbi Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Am J Respir Crit Care Med 180:499-505. 2009
    ..The 7-valent diphtheria-conjugated pneumococcal polysaccharide vaccine (PCV7) induces a more robust immune response than PPSV23 in healthy elderly adults...
  7. ncbi Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment
    deNay P Kirkpatrick
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Blvd, Birmingham, AL 35294, USA
    Curr Opin Pulm Med 15:100-4. 2009
    ..Given the scarcity of data about non-African-American minorities, this review will focus on the disparities in COPD susceptibility, diagnosis, and treatment between men and women and between African-Americans and whites...
  8. ncbi Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
    M T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Blvd, Birmingham, Alabama 35294, USA
    Thorax 63:301-5. 2008
    ..A study was undertaken to identify factors associated with beta blocker use in this setting and to determine whether their use is associated with decreased in-hospital mortality...
  9. ncbi COPD: racial disparities in susceptibility, treatment, and outcomes
    Mark T Dransfield
    Pulmonary Section, Birmingham VA Medical Center, Birmingham, AL 35294, USA
    Clin Chest Med 27:463-71, vii. 2006
    ..This article examines the available data concerning racial disparities in COPD susceptibility and care...
  10. ncbi Improving the lung cancer resection rate in the US Department of Veterans Affairs Health System
    Mark Thomas Dransfield
    Division of Pulmonary, Allergy, and Critical Care Medicine, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Clin Lung Cancer 7:268-72. 2006
    ..We also sought to identify the medical and nonmedical factors that influenced the use of surgery...
  11. ncbi Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, The University of Alabama at Birmingham, 35294, USA
    Respir Med 100:1110-6. 2006
    ..Some have suggested these groups are more susceptible to tobacco smoke. We examined this issue in our own population of COPD patients...
  12. ncbi Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach
    Mark T Dransfield
    The University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine, 215 THT1900 University Blvd, Birmingham, AL 35294, USA
    Expert Opin Pharmacother 6:13-25. 2005
    ..Guidelines also support the use of inhaled corticosteroids in patients with more advanced disease, and the role of these agents is discussed...
  13. ncbi Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease
    Mark T Dransfield
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, 215 THT, 1900 University Blvd, Birmingham, AL 35294, USA
    Expert Opin Pharmacother 5:1815-26. 2004
    ..Issues of patient selection as well as the pharmacology, efficacy and safety of the drug are discussed...
  14. ncbi Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipients
    Mark T Dransfield
    University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    J Heart Lung Transplant 23:110-4. 2004
    ..In an effort to minimize these differences and potentially improve outcomes, a standard set of procedural guidelines for all bronchoscopies was adopted in January 2000...
  15. ncbi Gender differences in the severity of CT emphysema in COPD
    Mark T Dransfield
    University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Chest 132:464-70. 2007
    ..We aimed to determine if there are gender differences in the severity of CT emphysema among COPD patients...
  16. ncbi Pneumococcal vaccination for patients with COPD: current practice and future directions
    Jeremy G Schenkein
    The University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Chest 133:767-74. 2008
    ....